Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
|
AMTG, 1985 | Amrinone | placebo | | | Negative | |
|
Lardoux, 1987 | Enoximone | placebo | | | Negative | |
EMTG, 1990 | Enoximone | placebo | | | Negative | |
WESG, 1991 | Enoximone | placebo | | | Negative | |
Cowley, 1994 | Enoximone | placebo | | | Negative | |
ESG, 2000 | Enoximone | placebo | | | Negative | |
EMOTE, 2007 | enoximone | placebo | | | - | |
ESSENTIAL (I and II), 2009 | enoximone | placebo | | Low risk of bias | Negative | NCT00051285 |
EMPOWER ongoing | enoximone | placebo (on top metoprolol) | | | - | NCT00077948 |
|
REFLECT II, 1991 | Flosequinan | placebo | | | Negative | |
Cowley, 1993 | Flosequinan | placebo | | | Negative | |
FACET, 1993 | Flosequinan | placebo | | | Negative | |
REFLECT, 1993 | Flosequinan | placebo | | | Negative | |
|
PRIME II, 1997 | ibopamine | placebo | | | Negative | |
|
MMTG, 1989 | Milrinone | placebo | | | Negative | |
PROMISE, 1991 | Milrinone | placebo | | | Negative | |
|
OPC-8212 MRG, 1990 | Vesnarinone | placebo | | | Negative | |
VSG, 1993 | Vesnarinone | placebo | | | Suggesting | |
VEST, 1998 | Vesnarinone | placebo | | | Negative | |